Development of an Androgen Receptor Inhibitor Targeting the N-Terminal Domain of Androgen Receptor for Treatment of Castration Resistant Prostate Cancer

SIMPLE SUMMARY: In almost all patients, the proliferation and growth of prostate cancer is driven by the androgen receptor. Given this critical role, inhibiting the androgen receptor is the standard of care following surgery or radiotherapy. However, the effectiveness of current anti-androgen therap...

Descripción completa

Detalles Bibliográficos
Autores principales: Ban, Fuqiang, Leblanc, Eric, Cavga, Ayse Derya, Huang, Chia-Chi Flora, Flory, Mark R., Zhang, Fan, Chang, Matthew E. K., Morin, Hélène, Lallous, Nada, Singh, Kriti, Gleave, Martin E., Mohammed, Hisham, Rennie, Paul S., Lack, Nathan A., Cherkasov, Artem
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8304761/
https://www.ncbi.nlm.nih.gov/pubmed/34298700
http://dx.doi.org/10.3390/cancers13143488

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8304761/
https://www.ncbi.nlm.nih.gov/pubmed/34298700
http://dx.doi.org/10.3390/cancers13143488

Ejemplares similares